Speakers
Andrea Perrone, MD
Head of Clinical Imaging, Translational Medicine, Merck, United States
David I. Raunig
Senior Vice President, Medical & Scientific Affairs, ICON, United States
Annette Schmid, PhD
Senior Director Scientific & Medical Services, Head of Oncology Imaging Strategy, PAREXEL International, United States
Steven Sun, PhD
Director, Janssen R&D, United States
Ohad Amit
Senior Director, Clinical Statistics, GlaxoSmithKline, United States
Robert Ford, MD
Founder and Principal, Clinical Trials Imaging Consulting, LLC, United States
Robert Ford, M.D., is a Founder of RadPharm and currently serves as Chief Medical Officer. Dr. Ford has been involved in approximately 250 oncology clinical trials where diagnostic imaging was used as an endpoint. He is a board-certified radiologist and is a member of the RECIST 2.0 Committee.
Ke Zhang, PhD
Director of Biostatistics, Pfizer, United States
S. Peter Eggleton, FFPM
Medical Director, GCDC Oncology, Merck Kgaa, Germany
Euan J. MacPherson, MSc
Principal Statistician, AstraZenca, United Kingdom
Richard Patt, MD
Principal, RadMD, United States
Lawrence H. Schwartz, MD
Chairman, Department of Radiology, Columbia University College of Physicians and Surgeons, United States
Na Xu, PhD
Senior Statistical Scientist, Genentech, A Member of the Roche Group, United States
Gregory V Goldmacher, MD, PhD, MBA
Senior Director, Translational Biomarkers, Merck & Co. Inc., United States
Susanta Sarkar
President, Cadenzamed LLC, United States
Ira Smalberg, MD
Radiologist, Tower Saint John's Imaging, United States
Have an account?